Janus Henderson Investors US
PBYI icon

Janus Henderson Investors US’s Puma Biotechnology PBYI Stock Holding History

Janus Henderson Investors US’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$82.2M Sell
2,209,599
-2,714
-0.1% -$99K 0.07% 332
2016
Q4 		$67.9M Sell
2,212,313
-75,461
-3% -$3.26M 0.06% 376
2016
Q3 		$153M Sell
2,287,774
-252,557
-10% -$12.8M 0.13% 214
2016
Q2 		$75.7M Buy
2,540,331
+594,821
+31% +$18.6M 0.06% 345
2016
Q1 		$57.1M Buy
1,945,510
+1,358,208
+231% +$61.4M 0.05% 401
2015
Q4 		$46M Buy
587,302
+24,637
+4% +$1.93M 0.04% 451
2015
Q3 		$42.4M Sell
562,665
-227,159
-29% -$21.5M 0.04% 452
2015
Q2 		$92.2M Buy
789,824
+240,674
+44% +$43.6M 0.08% 325
2015
Q1 		$130M Buy
549,150
+164,552
+43% +$35.2M 0.11% 251
2014
Q4 		$72.8M Buy
384,598
+87,173
+29% +$19.3M 0.06% 371
2014
Q3 		$71M Sell
297,425
-206,183
-41% -$42.3M 0.06% 348
2014
Q2 		$33.2M Buy
503,608
+202,362
+67% +$14.4M 0.03% 488
2014
Q1 		$31.4M Buy
301,246
+61,774
+26% +$7.26M 0.03% 482
2013
Q4 		$24.8M Buy
+239,472
New +$14.1M 0.02% 506

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Janus Henderson Investors US's PBYI Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Puma Biotechnology (PBYI) stake by 0.12% in Q1 2017, selling an estimated $99K and leaving 2,209,599 shares worth $82.2M. The position accounts for 0.07% of the portfolio, ranked #332.

Janus Henderson Investors US first reported a position in PBYI in Q4 2013 and has held it in 14 quarters since. The position peaked at $153M in Q3 2016. 136 funds tracked by Wall St. Rank hold PBYI as of Q1 2017.

  • Janus Henderson Investors US held 2,209,599 shares of Puma Biotechnology worth $82.2M as of Q1 2017.
  • Janus Henderson Investors US sold 2,714 Puma Biotechnology shares in Q1 2017, an estimated $99K.
  • Puma Biotechnology made up 0.07% of Janus Henderson Investors US's portfolio in Q1 2017, its #332 holding.
  • Janus Henderson Investors US first reported a position in Puma Biotechnology in Q4 2013 and has held it in 14 quarters since.
  • Janus Henderson Investors US's Puma Biotechnology position peaked at $153M in Q3 2016.
  • 136 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.